107 related articles for article (PubMed ID: 1855927)
1. Comparison of urinary nitrate, N-nitrosoproline, 7-methylguanine and 3-methyladenine levels in a human population at risk for gastric cancer.
Stillwell WG; Xu HX; Glogowski J; Wishnok JS; Tannenbaum SR; Correa P
IARC Sci Publ; 1991; (105):83-7. PubMed ID: 1855927
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of nitrate, N-nitrosoproline, 3-methyladenine, and 7-methylguanine in a Colombian population at high risk for stomach cancer.
Stillwell WG; Glogowski J; Xu HX; Wishnok JS; Zavala D; Montes G; Correa P; Tannenbaum SR
Cancer Res; 1991 Jan; 51(1):190-4. PubMed ID: 1988083
[TBL] [Abstract][Full Text] [Related]
3. Urinary markers for exposures to alkylating or nitrosating agents.
Wishnok JS; Tannenbaum SR; Stillwell WG; Glogowski JA; Leaf CD
Environ Health Perspect; 1993 Mar; 99():155-9. PubMed ID: 8319614
[TBL] [Abstract][Full Text] [Related]
4. In vivo nitrosoproline formation and other risk factors in Costa Rican children from high- and low-risk areas for gastric cancer.
Sierra R; Chinnock A; Ohshima H; Pignatelli B; Malaveille C; Gamboa C; Teuchmann S; Muñoz N; Bartsch H
Cancer Epidemiol Biomarkers Prev; 1993; 2(6):563-8. PubMed ID: 8268774
[TBL] [Abstract][Full Text] [Related]
5. Nitrate and N-nitrosoproline excretion in two Italian regions with contrasting rates of gastric cancer: the role of nitrate and other factors in endogenous nitrosation.
Knight T; Pirastu R; Palli D; Cocco P; Leach S; Packer P; Iannarilli R; Manca P; Møller H; Forman D
Int J Cancer; 1992 Mar; 50(5):736-9. PubMed ID: 1544707
[TBL] [Abstract][Full Text] [Related]
6. High urinary excretion of nitrate and N-nitrosoproline in opisthorchiasis subjects.
Srianujata S; Tonbuth S; Bunyaratvej S; Valyasevi A; Promvanit N; Chaivatsagul W
IARC Sci Publ; 1987; (84):544-6. PubMed ID: 3679440
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of N-nitrosamino acids and nitrate by inhabitants of high- and low-risk areas for esophageal cancer in Northern China: endogenous formation of nitrosoproline and its inhibition by vitamin C.
Lu SH; Ohshima H; Fu HM; Tian Y; Li FM; Blettner M; Wahrendorf J; Bartsch H
Cancer Res; 1986 Mar; 46(3):1485-91. PubMed ID: 3943105
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of N-nitrosamino acids and nitrate by inhabitants of high- and low-risk areas for stomach cancer in Poland.
Zatonski W; Ohshima H; Przewozniak K; Drosik K; Mierzwinska J; Krygier M; Chmielarczyk W; Bartsch H
Int J Cancer; 1989 Nov; 44(5):823-7. PubMed ID: 2583863
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of N-nitrosoproline in relation to consumption of raw and cooked vegetables in a Danish rural population.
Møller H; Landt J; Pedersen E; Jensen P; Autrup H; Jensen OM
IARC Sci Publ; 1991; (105):168-71. PubMed ID: 1855843
[TBL] [Abstract][Full Text] [Related]
10. The availability of dietary nitrate for the endogenous nitrosation of L-proline.
Knight TM; Forman D
IARC Sci Publ; 1987; (84):518-23. PubMed ID: 3679434
[TBL] [Abstract][Full Text] [Related]
11. Urinary N-nitrosoproline excretion: a further evaluation of the nitrosamine hypothesis of gastric carcinogenesis in precancerous conditions.
Hall CN; Kirkham JS; Northfield TC
Gut; 1987 Feb; 28(2):216-20. PubMed ID: 3557192
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of N-nitrosamino acids and nitrate by inhabitants in high- and low-risk areas for stomach cancer in northern Japan.
Kamiyama S; Ohshima H; Shimada A; Saito N; Bourgade MC; Ziegler P; Bartsch H
IARC Sci Publ; 1987; (84):497-502. PubMed ID: 3679430
[TBL] [Abstract][Full Text] [Related]
13. N-nitrosation of proline in smokers and nonsmokers.
Ladd KF; Newmark HL; Archer MC
J Natl Cancer Inst; 1984 Jul; 73(1):83-7. PubMed ID: 6588238
[TBL] [Abstract][Full Text] [Related]
14. Protein-related differences in the excretion of nitrosoproline and nitrate by the rat--possible modification of de novo nitrate synthesis.
Mallett AK; Walters DG; Rowland IR
Food Chem Toxicol; 1988 Oct; 26(10):831-5. PubMed ID: 3220325
[TBL] [Abstract][Full Text] [Related]
15. N-nitrosoproline excretion in the presence and absence of gastric disease.
Knight TM; Leach S; Forman D; Vindigni C; Packer P; Venitt S; Minacci C; Lorenzini L; Tosi P; Frosini G
Eur J Cancer; 1991; 27(4):456-61. PubMed ID: 1827720
[TBL] [Abstract][Full Text] [Related]
16. Increased endogenous nitrosation in smokers.
Ladd KF; Archer MC; Newmark HL
IARC Sci Publ; 1984; (57):811-7. PubMed ID: 6533068
[TBL] [Abstract][Full Text] [Related]
17. Quantitative estimation of endogenous nitrosation in humans by monitoring N-nitrosoproline excreted in the urine.
Ohshima H; Bartsch H
Cancer Res; 1981 Sep; 41(9 Pt 1):3658-62. PubMed ID: 7260920
[TBL] [Abstract][Full Text] [Related]
18. Urinary levels of N-nitroso compounds in relation to risk of gastric cancer: findings from the shanghai cohort study.
Xu L; Qu YH; Chu XD; Wang R; Nelson HH; Gao YT; Yuan JM
PLoS One; 2015; 10(2):e0117326. PubMed ID: 25658333
[TBL] [Abstract][Full Text] [Related]
19. N-nitrosoproline excretion in patients with gastric lesions and in a control population.
Knight TM; Forman D; Leach S; Packer P; Vindigni C; Minacci C; Lorenzini L; Tosi P; Frosini G; Marini M
IARC Sci Publ; 1988; (89):97-101. PubMed ID: 3198238
[TBL] [Abstract][Full Text] [Related]
20. Basal N-nitrosoproline formation and excretion in the ferret.
Dull BJ; Hotchkiss JH; Vecchio AJ
Food Chem Toxicol; 1986 Aug; 24(8):843-5. PubMed ID: 3781434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
